Prevalence of metabolic syndrome components among the elderly using three different definitions: A cohort study in Finland

Scandinavian Journal of Primary Health Care

Volumn 30, Issue 1, 2012, Pages 29-34

  Saukkonen, Tuula ^a,b   Jokelainen, Jari ^a   Timonen, Markku ^a,c   Cederberg, Henna ^a   Laakso, Mauri ^a,c   Härkönen, Pirjo ^d   Keinänen Kiukaanniemi, Sirkka ^a,c,e   Rajala, Ulla ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Oulu Occupational Health Centre   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d OULU DEACONESS INSTITUTE   (Finland)

^e Oulu Health Centre   (Finland)

Author keywords

definitions; Elderly population; IDF; metabolic syndrome; prevalence

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FINLAND; HUMAN; MALE; METABOLIC SYNDROME X; NOMENCLATURE; PREVALENCE;

AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; MALE; METABOLIC SYNDROME X; PREVALENCE; TERMINOLOGY AS TOPIC;

EID: 84857253622     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2012.654192     Document Type: Article

References (29)

1. Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007;117:204-10.
2. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-9.
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002;288:2709-16.
4. Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, et al. Impact of weight loss on the metabolic syndrome. Int J Obes (Lond) 2007;31:1442-8.
5. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: The Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006;61: 505-10.
6. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts incident stroke: A 14-year follow-up study in elderly people in Finland. Stroke 2008;39:1078-83.
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
8. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62.
9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23: 469-80.
10. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-421.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol 2005; 4:198-203.
12. Gause-Nilsson I, Gherman S, Kumar DD, Kennerfalk A, Steen B. Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetol 2006;43:120-6.
13. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Agespecific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007;7:220.
14. Sattar N, Gaw A, Scherbakova O, Ford I, O' Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-19.
15. Heyrman J, editor. EURACT Educational Agenda. Leuven: European Academy of Teachers in General General Practice (EURACT); 2005.
16. Rajala U, Keinanen-Kiukaanniemi S, Uusimaki A, Reijula K, Kivela SL. Prevalence of diabetes mellitus and impaired glucose tolerance in a middle-aged Finnish population. Scand J Prim Health Care 1995;13:222-8.
17. Verenpaineen Käypä hoito 2009 [Finnish guidelines for the management of hypertension 2009]. Available at: http:// www.kaypahoito.fi/ kohonnut
18. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
19. Mancia G, Laurent S, Gabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. Blood Press 2009;18:308-47.
20. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.
21. Diabeteksen Käypä hoito 2009 [Finnish guidelines for the management of diabetes 2009]. Available at: http://www.kaypahoito.fi/diabetes
22. Strandberg TE, Strandberg AY, Salomaa VV, Pitkala KH, Tilvis RS, Sirola J, et al. Explaining the obesity paradox: Cardiovascular risk, weight change, and mortality during long-term follow-up in men. Eur Heart J 2009;30:1720-7.
23. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
25. Eddy DM, Schlessinger L, Heikes K. The metabolic syndrome and cardiovascular risk: Implications for clinical practice. Int J Obes (Lond) 2008;32(Suppl 2):S5 - 10.
26. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: A 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007;28:857-64.
27. Motta M, Bennati E, Cardillo E, Passamonte M, Ferlito L, Malaguarnera M. The metabolic syndrome (MS) in the elderly: Considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Arch Gerontol Geriatr 2009;48:380-4.
28. Spigt M, Rikkers A, Doornbos M, Wouters E, Spitz I, Van AL, et al. The effect of screening on the prevalence of diagnosed type 2 diabetes in primary care. Scand J Prim Health Care 2009;27:232-7.
29. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-46.